Loading…
Unicycive Therapeutics, Inc. is projected to rise to $7.98 by 2027, a +59% move from its current price of $5.01. UNCY is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $4.78 | $5.02 | $5.27 | +0.11% |
| Aug 5 | $4.69 | $5.02 | $5.38 | +0.22% |
| Aug 6 | $4.62 | $5.03 | $5.47 | +0.33% |
| Aug 7 | $4.56 | $5.03 | $5.55 | +0.43% |
| Aug 8 | $4.52 | $5.04 | $5.62 | +0.54% |
| Aug 9 | $4.47 | $5.04 | $5.68 | +0.65% |
| Aug 10 | $4.44 | $5.05 | $5.74 | +0.76% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.44 | $5.05 | $5.74 | +0.76% |
| Week 2 | $4.24 | $5.09 | $6.11 | +1.53% |
| Week 3 | $4.10 | $5.13 | $6.41 | +2.30% |
| Week 4 | $3.99 | $5.16 | $6.69 | +3.08% |
| Week 5 | $3.90 | $5.20 | $6.95 | +3.86% |
| Week 6 | $3.82 | $5.24 | $7.19 | +4.65% |
| Week 7 | $3.75 | $5.28 | $7.44 | +5.45% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Unicycive Therapeutics, Inc. is a clinical-stage biotechnology company focused on kidney diseases in the United States. It identifies, develops, and commercializes therapies for the treatment of kidney diseases.
It develops oxylanthanum carbonate, a lanthanum-based phosphate binding agent, for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and UNI-494, a nicotinamide ester derivative and a selective ATP-sensitive mitochondrial potassium channel activator, which is in Phase I clinical trial for the treatment of acute kidney injury and pre-clinical stage for the treatment of chronic kidney disease. The company was incorporated in 2016 and is headquartered in Mountain View, California.
Unicycive Therapeutics, Inc. (UNCY) trades at $5.30, with a market capitalization of $145.18M and a market rank of 3780.
The stock sits in the small-cap biotechnology space, with a current price that aligns with the near-term technical picture. Forecasts indicate upside potential over the coming years, beginning with the 2026 average price of $5.30 and extending to substantial gains in later years.
By 2030, the average price is forecast at $11.84, with a max of $19.93 and a min of $7.59, implying meaningful upside from today and a 123.4% ROI on the 2030 reference. By 2040, the average price is forecast at $39.54 (max $83.24, min $18.05) with a 646% ROI, and by 2050 the average is projected at $91.06 (max $209.45, min $40.98) with a 1618.2% ROI.
A major floor 51.1% below — a decisive break under it would weaken the trend.
The nearest floor, 6.4% below — buyers have tended to step in here.
The nearest ceiling, 63.9% above — a clean break opens room to run.
A major ceiling 89.4% above — clearing it would confirm fresh momentum.
Key UNCY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of UNCY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.02 | Sell | $5.09 | Sell |
| MA 10 | $5.27 | Sell | $5.19 | Sell |
| MA 20 | $5.26 | Sell | $5.44 | Sell |
| MA 50 | $6.42 | Sell | $6.10 | Sell |
| MA 100 | $6.81 | Sell | $6.42 | Sell |
| MA 200 | $6.37 | Sell | $6.34 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.36 | Neutral |
| Stoch RSI (14) | 56.93 | Neutral |
| CCI (20) | -86.53 | Neutral |
| Williams %R (14) | -71.58 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | -0.20 | Sell |
| Bollinger %B (20,2) | 0.23 | Neutral |
| Stochastic %K (14) | 28.42 | Neutral |
| TRIX (15) | -1.04 | Sell |
| Awesome (5,34) | -0.95 | Sell |
| Ultimate (7,14,28) | 38.00 | Neutral |
| Momentum (10) | -0.37 | Sell |
| Aroon Osc (25) | -12.00 | Sell |
| Hull MA (9) | 4.89 | Buy |
| ADX (14) | 18.14 | Neutral |
| ATR (14) | 0.28 | Info |
The near-term technical picture remains bullish. The RSI14 sits at 40, with a 50-day simple moving average of $6.47 and a 200-day simple moving average of $6.37, indicating a still-cautious momentum around a rising trend. Support is at $4.69 and resistance at $8.21, framing the key levels to watch.
In the last 30 days, the price has traded within a range from a low of $3.84 to a high of $7.31, highlighting the current volatility and the pivotal zones between which the stock could move in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.69 | $5.01 | $8.49 | 0% | Neutral | |
| $5.91 | $7.98 | $11.61 | +59% | Bullish | |
| $7.15 | $10.21 | $15.79 | +104% | Bullish | |
| $7.15 | $10.68 | $17.31 | +113% | Bullish | |
| $6.92 | $10.79 | $18.16 | +115% | Bullish | |
| $8.02 | $13.00 | $22.60 | +159% | Bullish | |
| $7.31 | $12.30 | $22.02 | +145% | Bullish | |
| $9.14 | $15.94 | $29.29 | +218% | Bullish | |
| $12.99 | $23.44 | $44.10 | +368% | Bullish | |
| $12.68 | $23.66 | $45.50 | +372% | Bullish | |
| $15.46 | $33.84 | $71.22 | +575% | Bullish | |
| $35.20 | $78.22 | $179.90 | +14.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.69 | $5.01 | $6.42 | +0.00% |
| September 2026 | $4.27 | $5.17 | $6.51 | +3.10% |
| October 2026 | $4.51 | $5.53 | $7.10 | +7.05% |
| November 2026 | $5.01 | $6.20 | $8.07 | +12.08% |
| December 2026 | $5.15 | $6.43 | $8.49 | +3.78% |
Click any year to see its month-by-month UNCY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect UNCY to range from $4.69 to $8.49 through 2026. The $5.01 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The UNCY price prediction for 2027 points to an average of $7.98 (low $5.91, high $11.61) — a potential gain of +59% on today's $5.01. Buyers look set to stay in control over this stretch.
In 2028, UNCY is projected to trade between $7.15 and $15.79, averaging $10.21 — a potential gain of +104% from today's $5.01. That is up +28% on the projected 2027 average. Momentum favours further upside here.
Unicycive Therapeutics, Inc.'s 2029 outlook centres on $10.68, within a $7.15 to $17.31 range. That is up +5% on the projected 2028 average. That marks a +113% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, UNCY could reach as high as $18.16, with a base case around $10.79 and support toward $6.92 — roughly +115% from $5.01. Momentum favours further upside here.
Expect UNCY to range from $8.02 to $22.60 through 2031. The $13.00 average target implies a +159% move from current prices. That is up +20% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The UNCY price prediction for 2032 points to an average of $12.30 (low $7.31, high $22.02) — a potential gain of +145% on today's $5.01. Momentum favours further upside here.
In 2033, UNCY is projected to trade between $9.14 and $29.29, averaging $15.94 — a potential gain of +218% from today's $5.01. That is up +30% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Unicycive Therapeutics, Inc.'s 2034 outlook centres on $23.44, within a $12.99 to $44.10 range. That is up +47% on the projected 2033 average. That marks a +368% change versus current levels. Momentum favours further upside here.
By 2035, UNCY could reach as high as $45.50, with a base case around $23.66 and support toward $12.68 — roughly +372% from $5.01. Buyers look set to stay in control over this stretch.
Expect UNCY to range from $15.46 to $71.22 through 2040. The $33.84 average target implies a +575% move from current prices. That is up +43% on the projected 2035 average. Momentum favours further upside here.
The UNCY price prediction for 2050 points to an average of $78.22 (low $35.20, high $179.90) — a potential gain of +14.6x on today's $5.01. Buyers look set to stay in control over this stretch.
Investing $1,000 in UNCY today (≈ 199.600798 UNCY) could be worth
$15,611.93
+$14,611.93 (+1461%) by 2050 · US Dollar
Based on the average projected UNCY price of $78.22 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in UNCYwould be worth at today's price.
$1,000 invested in UNCY on Jul 31, 2025 (≈ 230.414738 UNCY) would be worth
$1,154.38
+$154.38 (+15.4%) today · 1.15× · US Dollar
Based on a UNCY entry price of $4.34 vs. today's $5.01.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.4 | $927.78 | -7.2% |
| 1 month ago | $5.28 | $948.86 | -5.1% |
| 3 months ago | $7.67 | $653.19 | -34.7% |
| 6 months ago | $6.45 | $776.74 | -22.3% |
| 1 year ago | $4.34 | $1,154.38 | +15.4% |
| All time (5.0y) ago | $26.5 | $189.06 | -81.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our UNCY forecast.
Our base-case forecast reaches $10.00 around 2028.
Implied market cap at $10.00: $273.93M
Forecasts project meaningful upside over the long term. The 2030 average price is $11.84, with a max of $19.93 and a min of $7.59, corresponding to a ROI of 123.4% and a bullish sentiment. The 2040 forecast shows an average of $39.54, a max of $83.24, and a min of $18.05, with a ROI of 646% and ongoing bullish sentiment.
By 2050, the average is projected at $91.06, with a max of $209.45 and a min of $40.98, yielding a ROI of 1618.2% and a bullish sentiment.
These figures illustrate substantial upside potential across the forecast horizon, but they are estimates, not guarantees, and are not financial advice. Market outcomes depend on multiple factors that can evolve over time.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $11.84, a min of $7.59, and a max of $19.93, with a ROI of 123.4% and a bullish sentiment.
Forecasts indicate bullish sentiment across multiple years, with the average price rising to $11.84 by 2030 and $91.06 by 2050, and ROIs reaching 123.4% (2030), 646% (2040), and 1618.2% (2050). These are estimates and not guarantees.
Yes. The forecast shows a 2034 max of $50.08 and a 2035 max of $51.10, with higher potential later in the horizon (e.g., 2040 max $83.24 and 2050 max $209.45).
Current price is $5.30 and market cap is $145.18M; the market rank is 3780.
Sentiment is BULLISH with RSI14 at 40. The SMA50 is $6.47 and the SMA200 is $6.37. Support is $4.69 and resistance is $8.21, with a 30-day range of $3.84 to $7.31.
Unicycive Therapeutics, Inc. Community Discussion
0Share your Unicycive Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.